Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Follicular

Explore clinical trials studying Lymphoma, Follicular. Study availability and eligibility vary by location and protocol.

1,362 public trials 202 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Follicular trial results

Completed

Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)

NCT00243087

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +25 more
Locations
  • Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States
  • James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States
  • M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States
View Trial Details
Completed

Study of Capivasertib in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT05008055

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Houston, Texas, United States
  • Research Site Victoria, British Columbia, Canada
View all 17 locations
View Trial Details
Completed

Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies

NCT02924402

Conditions
B-Cell Non-Hodgkins Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +50 more
Locations
  • Moores UC San Diego Cancer Center La Jolla, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Northside Hospital Atlanta, Georgia, United States
  • The University of Chicago Medicine Chicago, Illinois, United States
View all 23 locations
View Trial Details
Completed

Study of Virtual Reality-based Medical Device for Patients with Depressive Disorder

NCT05701345

Conditions
Depressive Disorder, Depressive Disorder, Major, Depressive Episode, +13 more
Locations
  • Inje University Ilsan Palk Hospital Ilsan, South Korea
  • Jeju National University Hospital Jeju City, South Korea
  • Seoul ST. Mary's Hospital Seoul, South Korea
  • Yeouido ST. Mary's Hospital Seoul, South Korea
View Trial Details
Completed

BTK Inhibitor BGB-3111 in Chinese Participants With Diffuse Large B-Cell Lymphoma (Non-GCB) and Indolent Lymphoma (FL and MZL)

NCT03520920

Conditions
Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +13 more
Locations
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology Wuhan, Hubei, China
  • The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China
  • Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details
Completed

Open-Label Study of Parsaclisib, in Japanese Participants With Relapsed or Refractory Follicular Lymphoma (CITADEL-213)

NCT04434937

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Ja-Aichi Anjo Kosei Hospital Anjo, Japan
  • University of Fukui Hospital Fukui, Japan
  • Jcho Kyushu Hospital Fukuoka, Japan
  • National Hospital Organization Kyushu Cancer Center Fukuoka, Japan
View all 30 locations
View Trial Details

Related conditions